ID 405175206 · FY 2018–2024 · 7 years
Subsidiary of შეზღუდული პასუხისმგებლობის საზოგადოება ბერლინ ჰემი 72445 დისთრიბუშენს (100.0%)
Georgian distribution arm of Berlin-Chemie/Menarini, the Italian-German pharmaceutical group, marketing its prescription medicines locally.
curated 2026-06-03berlin-chemie.comreportal.ge
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 9,025 | 32,888 | 46,877 | 50,100 | 43,284 | 50,523 | 72,981 | +41.7% |
| Total COGS | -6,196 | -21,286 | -28,541 | -34,788 | -28,660 | -38,343 | -65,429 | +48.1% |
| Gross Profit | 2,829 | 11,602 | 18,336 | 15,312 | 14,624 | 12,180 | 7,552 | +17.8% |
| Gross Margin | 31.3% | 35.3% | 39.1% | 30.6% | 33.8% | 24.1% | 10.3% | |
| Total Operating Expenses | -3,031 | -10,323 | -11,069 | -12,874 | -12,730 | -10,247 | -4,933 | +8.5% |
| EBITDA | -202 | 1,279 | 7,267 | 2,438 | 1,894 | 1,933 | 2,619 | nmf |
| EBITDA Margin | -2.2% | 3.9% | 15.5% | 4.9% | 4.4% | 3.8% | 3.6% | |
| Total D&A | -51 | -208 | -316 | -379 | -299 | -245 | -119 | +15.2% |
| EBIT / Operating Income | -253 | 1,071 | 6,951 | 2,059 | 1,595 | 1,688 | 2,500 | nmf |
| Total Interest Expense | -155 | -542 | -878 | -636 | -919 | -89 | -278 | +10.2% |
| Total Other Income | 40 | 331 | 368 | 591 | 0 | 0 | 0 | +145.4% |
| Profit Before Tax | -368 | 860 | 6,441 | 2,014 | 676 | 1,599 | 2,222 | nmf |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | -99 | -388 | +291.9% |
| Net Profit / (Loss) | -389 | 810 | 6,405 | 1,953 | 591 | 1,500 | 1,834 | nmf |
| Net Margin | -4.3% | 2.5% | 13.7% | 3.9% | 1.4% | 3.0% | 2.5% |
Ownership & directors from companyinfo.ge (public corporate registry).